Gassert Chad

Average Profitability
29.72%
Insider Buys Quantity
1
Insider Buys Sum
$139,342.50
Insider Sells Quantity
10
Insider Sells Sum
$12.09M

Insider Activity of Gassert Chad

According to the SEC Form 4 filings, Gassert Chad, being in a position of

  1. SVP - CORP. DEV. & STRATEGY at ANI Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 100000 shares for $6.55M,
    over all time since 2022-03-18, has bought 5000 shares for $139,343, and sold 200000 shares for $12.09M.

The largest purchase of all time was on 2022-03-18 and amounted to 5000 shares of ANI Pharmaceuticals, Inc. for $139,343.

The largest sale of all time was on 2024-04-01 and amounted to 20000 shares of ANI Pharmaceuticals, Inc. for $1.34M.

Biography of Gassert Chad

No biography is available at this moment.

2024-07-01SaleANI Pharmaceuticals, Inc.
ANIP
SVP - CORP. DEV. & STRATEGY
20,000
0.0924%
$63.44$1.27M0%
2024-06-03SaleANI Pharmaceuticals, Inc.
ANIP
SVP - CORP. DEV. & STRATEGY
20,000
0.0969%
$64.41$1.29M-4.72%
2024-05-01SaleANI Pharmaceuticals, Inc.
ANIP
SVP - CORP. DEV. & STRATEGY
20,000
0.0955%
$66.62$1.33M-7.75%
2024-04-01SaleANI Pharmaceuticals, Inc.
ANIP
SVP - CORP. DEV. & STRATEGY
20,000
0.0941%
$67.25$1.34M-7.66%
2024-03-11SaleANI Pharmaceuticals, Inc.
ANIP
SVP - CORP. DEV. & STRATEGY
20,000
0.0945%
$65.81$1.32M-4.36%
2023-10-02SaleANI Pharmaceuticals, Inc.
ANIP
SVP - CORP. DEV. & STRATEGY
20,000
0.0979%
$56.48$1.13M+6.15%
2023-09-01SaleANI Pharmaceuticals, Inc.
ANIP
SVP - CORP. DEV. & STRATEGY
20,000
0.0987%
$64.70$1.29M-5.74%
2023-08-01SaleANI Pharmaceuticals, Inc.
ANIP
SVP - CORP. DEV. & STRATEGY
20,000
0.096%
$51.06$1.02M+19.95%
2023-07-03SaleANI Pharmaceuticals, Inc.
ANIP
SVP - CORP. DEV. & STRATEGY
20,000
0.1207%
$53.43$1.07M+10.23%
2023-06-22SaleANI Pharmaceuticals, Inc.
ANIP
SVP - CORP. DEV. & STRATEGY
20,000
0.1215%
$51.32$1.03M+14.59%
2022-03-18PurchaseANI Pharmaceuticals, Inc.
ANIP
SVP - CORP. DEV. & STRATEGY
5,000
0.0317%
$27.87$139,343+29.72%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.